Can the success of TME for rectal cancer be emulated by CME (complete mesocolic excision)?

1. We are delighted toinvite you to the beautiful World Heritage City of Bergen and look forward to seeing you in Bergen in June. Venue: VilVite – Bergen Science Centre Thormøhlensgate 51 5006 Bergen INTERNATIONAL CONFERENCE ON ADVANCED TREATMENT OFCOLON CANCERImproving treatment of colon cancer. What is essential?JUNE 9.- 10. 2011 BERGEN, NORWAY Can the success of TME for rectal cancer be emulated by CME (complete mesocolic excision)? The University of Bergen, Dept. of Surgical Sciences, and Haraldsplass Deaconal Hospital, Department of Surgery, invite you to learn about the concept of radical colon cancer surgery and treatment from world class speakers. Organising committee: Professor dr. med. Karl Søndenaa kasoende@online.no Dr. med. Kari Erichsen kari.erichsen@haraldsplass.no The full course is registered for 16 hours. Fee: NOK 3200 (300 €) Practical information, registration form and hotel accommodation is available online at: http://colon.axacoevent.se/en/registration Pre- and post-congressional tours will also be available.

2. PROGRAM - BERGEN JUNE 9 - 10, 2011Improving treatment of colon cancer. What is essential?THURSDAY, JUNE 9Moderators Torbjörn Holm and Karl Søndenaa08.15 Introduction. Karl Søndenaa08.30 Resectional approach for colon and rectosigmoid cancer based on anatomy and lymphatic spread. Werner Hohenberger09.00 The Japanese approach to colon cancer resections based on the vascular anatomy of the colon and rectosigmoid. Kenichi Sugihara09.30 Turnbull’s good results in view of today’s concept of mesocolon and the central tie. Defining the surgical approach. Feza Remzi10.00Coffee break10.30 Differences between open and laparoscopic surgery? Kristian Storli11.00 When is the laparoscopic approach permissible? Kenichi Sugihara11.30 Discussion12.00-13.00 LunchModerators Arild Nesbakken and Werner Hohenberger 13.00 Overview of the radical colon cancer surgery project in Bergen. Karl Søndenaa13.30 Background data from the Stockholm region colon project. Torbjørn Holm13.45 Recent experience with the Stockholm region colon project. Richard Bernhoff14.00 Discussion14.30 Coffee break15.00 Adequate treatment of rectosigmoid cancer. Heinz Becker15.30 Size of specimen with CME evaluation, lymph node numbers, LNR and other specific issues for the pathologist to decide. Nick West16.00 Are micrometastases crucial to staging and survival? Arne Færden16.20–17.00 Discussion FRIDAY, June 10 Moderators Werner Hohenberger and Feza Remzi 08.30 Should pulmonary CRC metastases be resected? Tom Treasure 09.00 The treatment of hepatic, pulmonary and cerebral CRC metastases in Western Norway. Lessons for the colorectal surgeon. Arild Horn, Bjarte Hjelmeland and P-H Pedersen 09.30 The need for adjuvant chemotherapy. Is it evidence based and when? Halfdan Sørbye 09.45 Discussion 10.00 Coffee break 10.30 Treatment strategies for colon cancer at TNM stage IV. Gunnar Arbman 11.00 HIPEC treatment of intra-abdominal recurrence. Stein G. Larsen 11.20 Discussion 12.00–13.00 Lunch Moderators Torbjörn Holm and Karl Søndena 13.00 Lessons learned past and present in Oslo. Ole Sjo 13.15 Treatment of colon cancer in Northern Norway. Long distances - any significance for the patient and who should treat him? Rolv-Ole Lindsetmo 13.30 Prognosis of colon cancer compared with rectal cancer. Where lies the difference. Bjørn Nedrebø 13.45 Recent trends in colorectal cancer in Norway: incidence, management, and outcome. Arne Wibe 14.00 Coffee break 14.30 Morbidity and mortality after introduction of radical colon cancer surgery. Bjørg Furnes Panel debate: 14.45 Why do some achieve better results? Is the surgeon, hospital or dedication crucial? Werner Hohenberger 15.00 What can the Japanese experience teach others? Professor Kenichi Sugihara 15.15 Current teaching in the US. Feza Remzi 15.30–16.00 Closing remarks and discussion